{"id":28687,"date":"2016-11-05T17:34:25","date_gmt":"2016-11-05T16:34:25","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=28687"},"modified":"2016-11-06T09:44:56","modified_gmt":"2016-11-06T08:44:56","slug":"brasile-medico-e-farmaceutica-come-la-tecnologia-sta-cambiando-il-rapporto","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/brasile-medico-e-farmaceutica-come-la-tecnologia-sta-cambiando-il-rapporto\/","title":{"rendered":"Brazil. Medicine and pharmaceuticals: how technology is changing the relationship"},"content":{"rendered":"
\n

Free technology to support evidence-based clinical practice is the new bet of the pharmaceutical sector<\/p>\n<\/div>\n

\n

\"RisultatiIn order to circumvent an increasingly competitive market, pharmaceutical companies are investing in technology and information services to engage with the public. In an industry that has traditionally invested in relationships through sales reps, content marketing is growing in popularity. This is the case of Momenta Pharmaceuticals, a company established for three years in the market, betting on a complete platform to support clinical practice.<\/p>\n

Completely free for doctors who register on the site, the platform (which also works on mobile devices) offers complete access to scientific content, with a constantly updated library. Service users can access the complete Medline and DynaMed\u00ae networks, which in addition to carrying all the most important medical publications in the world, also support physician support tools and scientific calculators divided for different practices, such as medical equations , clinical criteria, decision algorithms and others.<\/p>\n

\"\"\u201cA comprehensive database for evidence-based medicine practice serves as a source of information and advocacy for clinicians dealing with specific cases. With access to the latest case studies, it is possible to identify the most personalized treatment, to ensure greater efficacy\u201d \u2013 says Dr Ailton Degering, Medical Manager \u2013\u00a0<\/span>\u201csince an accurate calculation of the optimal dosage of the drug is made, even for the rare cases, trying to strengthen our collaboration with the doctors beyond the sales representative.\u201d<\/p>\n

Access to the content and tools available is completely free, and the company undertakes to provide any element not found, subject to authorization from the author. To sign up, just talk to one of the 400 Momenta propagandists scattered throughout Brazil or at the login site http:\/\/momentafarma.com.br\/evidencia\/<\/a>. Once you sign up, you can download a mobile version to have unlimited access to the platform anywhere.<\/p>\n

\"RisultatiAbout Momenta Pharmaceuticals<\/strong><\/p>\n

Momenta is a pharmaceutical company, focused on prescription drugs, which operates the commercialization of a broad portfolio of products with activities in various medical specialties: among others psychiatry, gynecology, respiratory tract. The company is also responsible for the production of antibiotics, oral and injectable, also for sale to third parties who are interested in participating in this market. Our factory, which claims to be the birthplace of penicillin production in Brazil, is located in the Freguesia do \u00d3 district of S\u00e3o Paulo, occupying an area of 7,883m\u00b2, with the current production capacity of 2,700 .000 packaged units, divided into several lines. With high-performance equipment, in addition to satisfying its own demand, Momenta Farmaceutica offers services for national and international companies that want to outsource phases or the entire production process, providing solutions with quality and competitiveness.<\/p>\n

Sexta, 04 November 2016 \u2013 seq<\/span><\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Tecnologia gratuita per sostenere la pratica clinica basata sulle evidenze \u00e8 la nuova scommessa del settore farmaceutico Al fine di aggirare un mercato sempre pi\u00f9 competitivo, le aziende farmaceutiche stanno investendo in tecnologia e servizi di informazione per relazionarsi con il pubblico. In un settore che tradizionalmente ha investito in relazioni attraverso rappresentanti di vendita, …<\/p>","protected":false},"author":4,"featured_media":28693,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[54],"class_list":["post-28687","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-marketing"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/28687","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=28687"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/28687\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/28693"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=28687"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=28687"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=28687"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}